Blocking a cellular pathway halts tumor spread in lab studies

Researchers found that a protein called Neogenin suppresses cancer progression by interfering with a key growth-signaling pathway. The discovery could point toward new drug targets for treating metastatic tumors, offering potential clinical applications if validated in human trials.

Originaltitel: Neogenin suppresses tumor progression and metastasis via inhibiting Merlin/YAP signaling